These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11467775)

  • 1. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.
    Thant AA; Nawa A; Kikkawa F; Ichigotani Y; Zhang Y; Sein TT; Amin AR; Hamaguchi M
    Clin Exp Metastasis; 2000; 18(5):423-8. PubMed ID: 11467775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk.
    Ruhul Amin AR; Senga T; Oo ML; Thant AA; Hamaguchi M
    Genes Cells; 2003 Jun; 8(6):515-23. PubMed ID: 12786942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
    Qiu Q; Yang M; Tsang BK; Gruslin A
    Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1.
    Liu E; Thant AA; Kikkawa F; Kurata H; Tanaka S; Nawa A; Mizutani S; Matsuda S; Hanafusa H; Hamaguchi M
    Cancer Res; 2000 May; 60(9):2361-4. PubMed ID: 10811109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.
    Kadri Z; Petitfrère E; Boudot C; Freyssinier JM; Fichelson S; Mayeux P; Emonard H; Hornebeck W; Haye B; Billat C
    Cell Growth Differ; 2000 Nov; 11(11):573-80. PubMed ID: 11095246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin.
    Miyata Y; Sato T; Yano M; Ito A
    Mol Cancer Ther; 2004 Jul; 3(7):839-47. PubMed ID: 15252145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
    Chung TW; Lee YC; Kim CH
    FASEB J; 2004 Jul; 18(10):1123-5. PubMed ID: 15132991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway.
    Liu JF; Crépin M; Liu JM; Barritault D; Ledoux D
    Biochem Biophys Res Commun; 2002 May; 293(4):1174-82. PubMed ID: 12054499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cell spreading by v-Crk requires Ras-MEK-MAP kinase signaling.
    Liu Y; Hiraiwa Y; Liu E; Kurata H; Thant AA; Matsuda S; Hamaguchi M
    Oncogene; 2001 Sep; 20(41):5908-12. PubMed ID: 11593397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of thrombin-induced MAPK activation associated with cell proliferation in human cultured tracheal smooth muscle cells.
    Lin CC; Shyr MH; Chien CS; Wang CC; Chiu CT; Hsiao LD; Yang CM
    Cell Signal; 2001 Apr; 13(4):257-67. PubMed ID: 11306243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.
    Lobenhofer EK; Huper G; Iglehart JD; Marks JR
    Cell Growth Differ; 2000 Feb; 11(2):99-110. PubMed ID: 10714766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line.
    Sautin YY; Crawford JM; Svetlov SI
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C2010-9. PubMed ID: 11698260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta.
    Wert MM; Palfrey HC
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):175-82. PubMed ID: 11062070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental regulation of neuronal K(Ca) channels by TGFbeta1: an essential role for PI3 kinase signaling and membrane insertion.
    Lhuillier L; Dryer SE
    J Neurophysiol; 2002 Aug; 88(2):954-64. PubMed ID: 12163544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro.
    Cordes N; van Beuningen D
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):453-62. PubMed ID: 14751515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
    Zhang D; Brodt P
    Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways.
    Gu J; Fujibayashi A; Yamada KM; Sekiguchi K
    J Biol Chem; 2002 May; 277(22):19922-8. PubMed ID: 11891225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms.
    Somwar R; Sumitani S; Taha C; Sweeney G; Klip A
    Am J Physiol; 1998 Oct; 275(4):E618-25. PubMed ID: 9755080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.